- Okada, Hideho;
- Galluzzi, L;
- Vacchelli, E;
- Bravo-San, JM;
- Buqué, A;
- Senovilla, L;
- Baracco, EE;
- Bloy, N;
- Castoldi, F;
- Abastado, JP;
- Agostinis, P
During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for us
